BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15451046)

  • 1. Effects of drug countermeasures for space motion sickness on working memory in humans.
    Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
    Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man.
    Weerts AP; De Meyer G; Pauwels G; Vanspauwen R; Dornhoffer JL; Van de Heyning PH; Wuyts FL
    Audiol Neurootol; 2012; 17(4):235-42. PubMed ID: 22517315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
    Dornhoffer J; Chelonis JJ; Blake D
    Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of treatment strategies for Space Motion Sickness.
    Davis JR; Jennings RT; Beck BG
    Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention of motion sickness in orbital flight.
    Graybiel A
    Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airsickness prevention in helicopter passengers.
    Estrada A; LeDuc PA; Curry IP; Phelps SE; Fuller DR
    Aviat Space Environ Med; 2007 Apr; 78(4):408-13. PubMed ID: 17484344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of the proposed Space Shuttle antimotion sickness medications.
    Hordinsky JR; Schwartz E; Beier J; Martin J; Aust G
    Acta Astronaut; 1982; 9(6-7):375-83. PubMed ID: 11541691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing space motion sickness.
    Jennings RT
    J Vestib Res; 1998; 8(1):67-70. PubMed ID: 9416592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
    Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
    Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.
    Weerts AP; Pattyn N; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2014 Jul; 28(7):655-64. PubMed ID: 24346808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Space motion sickness.
    Homick JL
    Acta Astronaut; 1979 Oct; 6(10):1259-72. PubMed ID: 11902170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promethazine as a motion sickness treatment: impact on human performance and mood states.
    Cowings PS; Toscano WB; DeRoshia C; Miller NE
    Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Various anti-motion sickness drugs and core body temperature changes.
    Cheung B; Nakashima AM; Hofer KD
    Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.
    Fadda P; Robinson L; Fratta W; Pertwee RG; Riedel G
    Behav Brain Res; 2006 Apr; 168(2):307-11. PubMed ID: 16406104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment strategies for Space Motion Sickness.
    Davis JR; Jennings RT; Beck BG
    Acta Astronaut; 1993 Aug; 29(8):587-91. PubMed ID: 11541638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.